Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia

Ann Intern Med. 2021 Oct;174(10):JC111. doi: 10.7326/ACPJ202110190-111. Epub 2021 Oct 5.

Authors

Steven Y C Tong¹, Neta Petersiel¹

Affiliation

¹ University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (S.Y.T., N.P.).

PMID: 34606317
DOI: 10.7326/ACPJ202110190-111

Abstract

Guimarães PO, Quirk D, Furtado RH, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385:406-15. 34133856.

Publication types

Comment

MeSH terms

COVID-19*
Humans
Piperidines
Pyrimidines
Respiratory Insufficiency*
SARS-CoV-2

Substances

Piperidines
Pyrimidines
tofacitinib